Nanoreagents Against the Blood-Testis Barrier: A Strategy for Diagnosing and Treating Male Reproductive System Diseases
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Male reproductive health represents a critical yet challenging area of medical science, where conventional diagnostics and therapies are often limited by physiological barriers-particularly the blood-testis barrier (BTB)-and the complex etiology of disorders such as infertility, prostate cancer, and erectile dysfunction. In recent years, nanoreagents has emerged as a transformative tool, enabling unprecedented advances in drug delivery, imaging, and therapeutic precision. This review systematically examines the application of diverse nanomaterials-including metal nanoparticles, lipid-based systems, polymeric carriers, and natural derivatives such as nanobodies, extracellular vesicles, and cell membrane-coated nanoparticles-in the context of male reproductive medicine. These platforms facilitate targeted drug delivery across the BTB, enhance local drug bioavailability, minimize systemic toxicity, and support sustained release profiles. In diagnostic imaging, nanotechnology augments modalities such as MRI, PET, and photoacoustic imaging. Furthermore, natural biomaterials offer biocompatible and immunologically inert strategies for drug encapsulation and targeted transport, improving both efficacy and safety. Despite these promising developments, challenges remain in standardization, long-term biosafety, and scalable synthesis. Nevertheless, the integration of nanotechnology in male reproductive health is poised to redefine treatment paradigms, offering personalized, efficient, and minimally invasive solutions. As research progresses, nano-based approaches hold significant potential to address unmet clinical needs and improve reproductive outcomes worldwide.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Nanoreagents Against the Blood-Testis Barrier: A Strategy for Diagnosing and Treating Male Reproductive System Diseases
- Date Crossref
- 01/01/2026
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Chengdu Women's and Children's Central Hospital pays non établi dans la noticeÉtablissement de santé
-
Chengdu University of Traditional Chinese Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Chengdu Medical College Center of Women's and Children's Health Medical Research and Technology Innovation pays non établi dans la noticeÉtablissement de santé
-
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital pays non établi dans la noticeÉtablissement de santé
-
School of Medicine and Life sciences pays non établi dans la noticeUniversité ou école supérieure
-
School of Clinical Laboratory Medicine pays non établi dans la noticeUniversité ou école supérieure
-
School of Medicine of University of Electronic Science and Technology of China Department of Haematology pays non établi dans la noticeUniversité ou école supérieure
Chengdu Women's and Children's Central Hospital, Chengdu University of Traditional Chinese Medicine et Center of Women's and Children's Health Medical Research and Technology Innovation — Chengdu Medical College, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.